8-K 1 d38153d8k.htm 8-K 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 18, 2015

 

 

SIGMA-ALDRICH CORPORATION

(Exact name of Registrant as specified in its charter)

 

 

 

 

Delaware   43-1050617

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

3050 Spruce Street

St. Louis, Missouri 63103

(314) 771-5765

(Address of Principal Executive Offices including Zip Code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.01 Completion of Acquisition or Disposition of Assets.

On November 18, 2015, Merck KGaA (“Merck”) completed its acquisition of Sigma-Aldrich Corporation (“Sigma”). As a result, Sigma is now an indirect, wholly-owned subsidiary of Merck.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    SIGMA-ALDRICH CORPORATION
Dated: November 18, 2015     By:   /s/ Udit Batra
    Name:   Udit Batra
    Title:   Director and Chief Executive Officer